AC-45287 - itraconazole-99 | 84625-61-6
Es wurde leider kein Produkt mit der Referenz AC-45287 gefunden, aber bitte schauen Sie sich die folgenden ähnlichen Produkte an:
Itraconazole
CAS:ItraconazoleFormel:C35H38CI2N8O4Reinheit:99.7%Farbe und Form:White To Off-WhiteMolekulargewicht:900.11055Itraconazole
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormel:C35H38ClN8O4Farbe und Form:White PowderMolekulargewicht:669.27045Ref: IN-DA003R60
1g30,00€5g50,00€10g77,00€1kgNachfragen25g133,00€50g161,00€100g297,00€25mg24,00€500g503,00€100mg25,00€250mg25,00€Itraconazole
CAS:Itraconazole (R51211) is a triazole antifungal agent that inhibits cytochrome P-450-dependent enzymes required for ERGOSTEROL synthesis.Formel:C35H38Cl2N8O4Reinheit:98% - 99.90%Farbe und Form:Off-White Crystalline SolidMolekulargewicht:705.63Itraconazole
CAS:Formel:C35H38Cl2N8O4Reinheit:99.0 - 101.0 % (dried basis)Farbe und Form:White or almost white powderMolekulargewicht:705.63Itraconazole
CAS:Kontrolliertes ProduktFormel:C35H38Cl2N8O4Farbe und Form:NeatMolekulargewicht:705.63Itraconazole
CAS:Formel:C35H38Cl2N8O4Reinheit:>98.0%(T)(HPLC)Farbe und Form:White to Almost white powder to crystalMolekulargewicht:705.64Itraconazole
CAS:Kontrolliertes Produkt<p>Applications Itraconazole is an orally active antimycotic structurally related to Ketoconazole. Antifungal. It is a COVID19-related research product.<br>References Espinel-Ingroff, A., et al.: Antimicrob. Agents Chemother., 26, 5 (1984); Heykants, J., et al.: Mycoses, 32, Suppl 1, 67 (1989); Sugar, A.M.,et al.: Curr. Clin. Top. Infect. Dis., 13, 74 (1993);<br></p>Formel:C35H38Cl2N8O4Farbe und Form:White To Off-WhiteMolekulargewicht:705.63Itraconazole
CAS:Itraconazole is an anti-fungal drug that inhibits the synthesis of ergosterol, a component of the fungal cell membrane. It also has been shown to have a glucose-lowering effect in the treatment of acute leukemia and may be used to diagnose hematopoietic stem cell or leukemia. Itraconazole is available as an oral tablet and can be administered for primary care in patients with wild-type strains of Aspergillus fumigatus, Candida albicans, Cryptococcus neoformans, Histoplasma capsulatum, and Trichophyton mentagrophytes. The drug binds to ergosterol in the fungal cell membrane and prevents it from being inserted into the membrane. This decreases the permeability of the plasma membrane, causing leakage of cellular contents.Formel:C35H38Cl2N8O4Reinheit:Min. 98.5 Area-%Farbe und Form:White PowderMolekulargewicht:705.63 g/molITRACONAZOLE CRS
CAS:ITRACONAZOLE CRSFormel:C35H38Cl2N8O4Farbe und Form:White. Powder.Molekulargewicht:705.6334
